Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 0615-8628

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 0615-8628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Esomeprazole 8628 1)

Chemical structure depicting esomeprazole magnesium trihydrate, showing the molecular arrangement with methoxy and methyl groups, sulfur-oxygen double bond, nitrogen atoms in the pyridine and benzimidazole rings, and coordination with magnesium ion and water molecules.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole 8628 2)

A line graph showing percent maintained over six months for different doses of Esomeprazole Magnesium (40 mg, 20 mg, 10 mg) compared to a placebo. The y-axis represents percent maintained (0-100%) and the x-axis represents months (0 to 6) with scheduled visits indicated. The 40 mg dose maintains the highest percentage over time, with decreasing percentages for lower doses and placebo.*

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole 8628 3)

A line graph depicting percent maintained over 6 months for Esomeprazole Magnesium at strengths of 40 mg, 20 mg, 10 mg, and placebo. The y-axis shows percent maintained, and the x-axis represents time in months with scheduled visits marked. The 40 mg and 20 mg lines remain high, while 10 mg and placebo decline over time.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole 8628 4)

Line graph displaying the percent of patients symptom-free over 28 diary days, comparing Esomeprazole Magnesium delayed-release capsules 40 mg, 20 mg, and placebo. The vertical axis shows the percent symptom-free, and the horizontal axis shows diary days from 0 to 28. Lines with distinct markers represent each group.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole 8628 5)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses, compared to placebo. The graph tracks symptom relief progress, with 40 mg and 20 mg doses showing higher symptom-free percentages than placebo over time.*

FDA Label Image

Principal Display Panel (Esomeprazole 8628 6)

Esomeprazole Magnesium delayed-release capsules USP 40 mg packaging label from NCS HealthCare of KY, LLC dba Vangard Labs. The label includes multiple barcode strips with lot number 8628 and mentions the product is for institutional use. Manufactured by Aurobindo, packed by Vangard in Glasgow, KY. Quantity is 30 capsules, oral route.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.